Cas 6565-75-9,1-(2,4-dimethoxyphenyl)octan-1-one

6565-75-9

Post Buying Request

Basic information

Product Name: 1-(2,4-dimethoxyphenyl)octan-1-one
Synonyms: 1-(2,4-dimethoxyphenyl)octan-1-one
CAS NO:6565-75-9
Molecular Formula:
Molecular Weight: 264.365
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-(2,4-dimethoxyphenyl)octan-1-one(CAS DataBase Reference)
NIST Chemistry Reference: 1-(2,4-dimethoxyphenyl)octan-1-one(6565-75-9)
EPA Substance Registry System: 1-(2,4-dimethoxyphenyl)octan-1-one(6565-75-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 6565-75-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

6565-75-9 Suppliers

Recommended suppliers

6565-75-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 6565-75-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,5,6 and 5 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 6565-75:
(6*6)+(5*5)+(4*6)+(3*5)+(2*7)+(1*5)=119
119 % 10 = 9
So 6565-75-9 is a valid CAS Registry Number.

6565-75-9Upstream product

6565-75-9Downstream Products

6565-75-9Relevant academic research and scientific papers

Ketide compounds, method for manufacturing, and use for treating diabetes thereof

-

Paragraph 0078; 0178-0181; 0223-0225, (2019/08/27)

The present invention relates to ketide compounds, as well as ketide compounds. The present invention relates to a method for preparing a ketide compound, and a use thereof, in which various anti-diabetic TMPA derivative designs can be induced, and is effective in comparison with existing multi-stage synthesis. In addition, the ketide compounds according to the present invention have strong AMPMPK activity and are expected to be useful as a therapeutic agent for diabetes. (by machine translation)

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 6565-75-9